CSIMarket


Hologic Inc  (HOLX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Hologic Inc

HOLX's Fundamental analysis








Hologic Inc's sales fell by -0.85 % in II. Quarter 2024 from the same quarter a year ago. Ranking at No. 1819

Medical Laboratories industry recorded growth of revenues by 2.67 %

Hologic Inc's net profit decreased by -22.24 % in II. Quarter 2024 year on year, to $170 millions.

More on HOLX's Growth


Hologic Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Hologic Inc realized cash reduction of $ -1.69 per share in trailing twelve-month period.
Company
29.9
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 4.6.
Medical Laboratories industry's Price to Sales ratio is at 3.07.


More on HOLX's Valuation
 
 Total Debt (Millions $) 2,552
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 582,704
 Net Income/Employee (TTM) $ 89,559
 Receivable Turnover (TTM) 6.15
 Tangible Book Value (Per Share $) 3.37

Hologic Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Hologic Inc realized cash outflow of $ -1.69per share in trailing twelve-month period.
Company
29.9
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 4.6.
Medical Laboratories industry's Price to Sales ratio is at 3.07.

Hologic Inc Price to Book Ratio is at 3.84 lower than Industry Avg. of 431.45. and higher than S&P 500 Avg. of 0.01

More on HOLX's Valuation

  Market Capitalization (Millions $) 18,611
  Shares Outstanding (Millions) 238
  Employees 6,944
  Revenues (TTM) (Millions $) 4,046
  Net Income (TTM) (Millions $) 622
  Cash Flow (TTM) (Millions $) -402
  Capital Exp. (TTM) (Millions $) -93
  Total Debt (Millions $) 2,552
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 582,704
  Net Income/Employee(TTM) $ 89,559
  Receivable Turnover Ratio (TTM) 6.15
  Tangible Book Value (Per Share $) 3.37

  Market Capitalization (Millions $) 18,611
  Shares Outstanding (Millions) 238
  Employees 6,944
  Revenues (TTM) (Millions $) 4,046
  Net Income (TTM) (Millions $) 622
  Cash Flow (TTM) (Millions $) -402
  Capital Exp. (TTM) (Millions $) -93


    HOLX's Profitability Comparisons
Hologic Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2024 to 20.67 % from 19.56 % in I. Quarter.

Hologic Inc net profit margin of 16.69 % is currently ranking no. 5 in Medical Laboratories industry, ranking no. 57 in Healthcare sector and number 721 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 3.98
  Total Debt to Equity (MRQ) 0.53
  Tangible Leverage Ratio (MRQ) 4.35
  Asset Turnover Ratio (TTM) 0.45
  Inventory Turnover Ratio (TTM) 1.41



Hologic Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2024 to 20.67 % from 19.56 % in I. Quarter.

Hologic Inc net profit margin of 16.69 % is currently ranking no. 5 in Medical Laboratories industry, ranking no. 57 in Healthcare sector and number 721 in S&P 500.

More on HOLX's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com